Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2011-10-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
NCT01265953
Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels
NCT00803699
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
NCT00099008
Soy, Selenium and Breast Cancer Risk
NCT00555386
Quercetin's Effect on Bone Health and Inflammatory Markers
NCT05371340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo given daily
Placebo
Placebo capsule given daily
Methylselenocysteine
Methylselenocysteine given daily
Methylselenocysteine
Methylselenocysteine capsule given daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methylselenocysteine
Methylselenocysteine capsule given daily
Placebo
Placebo capsule given daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant
* Breast feeding
* Heart conditions
* Chronic lung disease
* Cancer therapy (current or past)
21 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Howard M. Kipen, MD, MPH
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Howard M. Kipen, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey
Helmut Zarbl, MD
Role: STUDY_CHAIR
Rutgers, The State University of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Environmental and Occupational Health Sciences Institute
Piscataway, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0220100243
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.